Cargando…
Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancer
Colorectal cancer (CRC) is a biologically and clinically heterogeneous disease. Even though many recurrent genomic alterations have been identified that may characterize distinct subgroups, their biological impact and clinical significance as prognostic indicators remain to be defined. The tumor sup...
Autores principales: | Burgermeister, Elke, Höde, Patrick, Betge, Johannes, Gutting, Tobias, Merkel, Andreas, Wu, Wen, Tänzer, Marc, Mossner, Maximilian, Nowak, Daniel, Magdeburg, Julia, Rückert, Felix, Sticht, Carsten, Breitkopf-Heinlein, Katja, Schulte, Nadine, Härtel, Nicolai, Belle, Sebastian, Post, Stefan, Gaiser, Timo, Heppner, Barbara Ingold, Behrens, Hans-Michael, Röcken, Christoph, Ebert, Matthias P.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689568/ https://www.ncbi.nlm.nih.gov/pubmed/29156678 http://dx.doi.org/10.18632/oncotarget.20950 |
Ejemplares similares
-
Myotubularin-related protein 7 inhibits insulin signaling in colorectal cancer
por: Weidner, Philip, et al.
Publicado: (2016) -
A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)
por: Meindl-Beinker, Nadja M., et al.
Publicado: (2019) -
Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer
por: Friedrich, Teresa, et al.
Publicado: (2016) -
A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)
por: Betge, Johannes, et al.
Publicado: (2018) -
The drug-induced phenotypic landscape of colorectal cancer organoids
por: Betge, Johannes, et al.
Publicado: (2022)